261 related articles for article (PubMed ID: 19095974)
21. Biomarkers for Prediction of Cardiovascular Events in Community-Dwelling Adults Aged 40 or Older.
Chong Y; Ren Q; Li Y; Li C; Feng F; Zhou Y
Int Heart J; 2020 Jan; 61(1):109-114. PubMed ID: 31875617
[TBL] [Abstract][Full Text] [Related]
22. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.
Everett BM; Kurth T; Buring JE; Ridker PM
J Am Coll Cardiol; 2006 Dec; 48(11):2235-42. PubMed ID: 17161253
[TBL] [Abstract][Full Text] [Related]
23. Incident CHD and ischemic stroke associated with lipoprotein(a) by levels of Factor VIII and inflammation.
Colantonio LD; Goonewardena SN; Wang Z; Jackson EA; Farkouh ME; Li M; Malick W; Kent ST; López JAG; Muntner P; Bittner V; Rosenson RS
J Clin Lipidol; 2023; 17(4):529-537. PubMed ID: 37331900
[TBL] [Abstract][Full Text] [Related]
24. Lipoprotein-associated phospholipase A(2) and risk of congestive heart failure in older adults: the Cardiovascular Health Study.
Suzuki T; Solomon C; Jenny NS; Tracy R; Nelson JJ; Psaty BM; Furberg C; Cushman M
Circ Heart Fail; 2009 Sep; 2(5):429-36. PubMed ID: 19808373
[TBL] [Abstract][Full Text] [Related]
25. Peripheral arterial tonometry for risk stratification in men with coronary artery disease.
Heffernan KS; Karas RH; Patvardhan EA; Jafri H; Kuvin JT
Clin Cardiol; 2010 Feb; 33(2):94-8. PubMed ID: 20186990
[TBL] [Abstract][Full Text] [Related]
26. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
27. Lipoprotein-associated phospholipase A2 and C-reactive protein for risk-stratification of patients with TIA.
Cucchiara BL; Messe SR; Sansing L; MacKenzie L; Taylor RA; Pacelli J; Shah Q; Kasner SE
Stroke; 2009 Jul; 40(7):2332-6. PubMed ID: 19461040
[TBL] [Abstract][Full Text] [Related]
28. Lp-PLA
Fatemi S; Gottsäter A; Zarrouk M; Engström G; Melander O; Persson M; Acosta S
Sci Rep; 2019 Apr; 9(1):5609. PubMed ID: 30948779
[TBL] [Abstract][Full Text] [Related]
29. Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study.
Aronis KN; Zhao D; Hoogeveen RC; Alonso A; Ballantyne CM; Guallar E; Jones SR; Martin SS; Nazarian S; Steffen BT; Virani SS; Michos ED
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29246963
[TBL] [Abstract][Full Text] [Related]
30. High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2 stability before and after stroke and myocardial infarction.
Elkind MS; Leon V; Moon YP; Paik MC; Sacco RL
Stroke; 2009 Oct; 40(10):3233-7. PubMed ID: 19644070
[TBL] [Abstract][Full Text] [Related]
31. Association of carotid plaque Lp-PLA(2) with macrophages and Chlamydia pneumoniae infection among patients at risk for stroke.
Atik B; Johnston SC; Dean D
PLoS One; 2010 Jun; 5(6):e11026. PubMed ID: 20543948
[TBL] [Abstract][Full Text] [Related]
32. Relation between lipoprotein-associated phospholipase A
Zhou F; Liu Y; Shi H; Huang Q; Zhou J
Neurol Sci; 2018 Sep; 39(9):1591-1596. PubMed ID: 29938341
[TBL] [Abstract][Full Text] [Related]
33. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) and risk of cardiovascular disease in older adults: results from the Cardiovascular Health Study.
Jenny NS; Solomon C; Cushman M; Tracy RP; Nelson JJ; Psaty BM; Furberg CD
Atherosclerosis; 2010 Apr; 209(2):528-32. PubMed ID: 19804884
[TBL] [Abstract][Full Text] [Related]
34. Mediation of Systemic Inflammation on Insulin Resistance and Prognosis of Nondiabetic Patients With Ischemic Stroke.
Jin A; Wang S; Li J; Wang M; Lin J; Li H; Meng X; Wang Y; Pan Y
Stroke; 2023 Mar; 54(3):759-769. PubMed ID: 36722344
[TBL] [Abstract][Full Text] [Related]
35. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany.
Koenig W; Khuseyinova N; Löwel H; Trischler G; Meisinger C
Circulation; 2004 Oct; 110(14):1903-8. PubMed ID: 15451783
[TBL] [Abstract][Full Text] [Related]
36. Lp-PLA
Wang Y; Hu S; Ren L; Lei Z; Lan T; Cai J; Li C
Neurol Res; 2019 Jan; 41(1):1-8. PubMed ID: 30296199
[No Abstract] [Full Text] [Related]
37. Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study.
Yang EY; Nambi V; Tang Z; Virani SS; Boerwinkle E; Hoogeveen RC; Astor BC; Mosley TH; Coresh J; Chambless L; Ballantyne CM
J Am Coll Cardiol; 2009 Dec; 54(25):2388-95. PubMed ID: 20082929
[TBL] [Abstract][Full Text] [Related]
38. Lipoprotein-associated phospholipase A2 and risk of stroke.
Gorelick PB
Am J Cardiol; 2008 Jun; 101(12A):34F-40F. PubMed ID: 18549870
[TBL] [Abstract][Full Text] [Related]
39. Estimating the hazard rate difference from case-cohort studies.
Hu JK; Chan KCG; Couper DJ; Breslow NE
Eur J Epidemiol; 2021 Nov; 36(11):1129-1142. PubMed ID: 34125343
[TBL] [Abstract][Full Text] [Related]
40. Joint Effect of Carotid Plaque and C-Reactive Protein on First-Ever Ischemic Stroke and Myocardial Infarction?
Eltoft A; Arntzen KA; Wilsgaard T; Hansen JB; Mathiesen EB; Johnsen SH
J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29773576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
